SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-260412
Filing Date
2013-06-17
Accepted
2013-06-17 08:16:23
Documents
2
Period of Report
2013-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d554995d8ka.htm 8-K/A 19069
2 EX-99.1 d554995dex991.htm EX-99.1 497678
  Complete submission text file 0001193125-13-260412.txt   518056
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-14956 | Film No.: 13915651
SIC: 2834 Pharmaceutical Preparations